{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:11:46Z","timestamp":1784131906995,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ciclopirox (CPX) modulates multiple cellular pathways involved in the\ngrowth of a variety of tumor cell types. However, the effects of CPX on colorectal\ncancer (CRC) and the underlying mechanisms for its antitumor activity remain\nunclear. Herein, we report that CPX exhibited strong antitumorigenic properties in\nCRC by inducing cell cycle arrest, repressing cell migration, and invasion by\naffecting N-cadherin, Snail, E-cadherin, MMP-2, and MMP-9 expression, and disruption\nof cellular bioenergetics contributed to CPX-associated inhibition of cell growth,\nmigration, and invasion. Interestingly, CPX-induced reactive oxygen species (ROS)\nproduction and impaired mitochondrial respiration, whereas the capacity of\nglycolysis was increased. CPX (20\u2009mg\/kg, intraperitoneally) substantially\ninhibited CRC xenograft growth in vivo. Mechanistic studies revealed that the\nantitumor activity of CPX relies on apoptosis induced by ROS-mediated endoplasmic\nreticulum (ER) stress in both 5-FU-sensitive and -resistant CRC cells. Our data\nreveal a novel mechanism for CPX through the disruption of cellular bioenergetics\nand activating protein kinase RNA-like endoplasmic reticulum kinase (PERK)-dependent\nER stress to drive cell death and overcome drug resistance in CRC, indicating that\nCPX could potentially be a novel chemotherapeutic for the treatment of CRC.<\/jats:p>","DOI":"10.1038\/s41419-020-02779-1","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T07:02:46Z","timestamp":1595833366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Ciclopirox activates PERK-dependent endoplasmic reticulum stress\nto drive cell death in colorectal cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Jianjun","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"2779_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates\nof incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.\n68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"2779_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","volume":"30","author":"W Chen","year":"2018","unstructured":"Chen, W. et al. Cancer incidence and mortality in China, 2014.\nChin. J. Cancer Res.\n30, 1\u201312 (2018).","journal-title":"Chin. J. Cancer Res."},{"key":"2779_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cgh.2012.08.037","volume":"11","author":"P Lochhead","year":"2013","unstructured":"Lochhead, P. & Chan, A. T. Statins and colorectal cancer.\nClin. Gastroenterol. Hepatol.\n11, 109\u2013118 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2779_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-4632.2004.02331.x","volume":"45","author":"AK Gupta","year":"2006","unstructured":"Gupta, A. K. & Nicol, K. A. Ciclopirox 1% shampoo for the\ntreatment of seborrheic dermatitis. Int. J.\nDermatol.\n45, 66\u201369 (2006).","journal-title":"Int. J. Dermatol."},{"key":"2779_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2165\/00003495-198529040-00002","volume":"29","author":"SG Jue","year":"1985","unstructured":"Jue, S. G., Dawson, G. W. & Brogden, R. N. Ciclopirox\nolamine 1% cream. A preliminary review of its antimicrobial activity and\ntherapeutic use. Drugs\n29, 330\u2013341 (1985).","journal-title":"Drugs"},{"key":"2779_CR6","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.2174\/1381612822666160530151209","volume":"22","author":"T Shen","year":"2016","unstructured":"Shen, T. & Huang, S. Repositioning the old fungicide\nciclopirox for new medical uses. Curr. Pharm.\nDes.\n22, 4443\u20134450 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"2779_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ijc.10515","volume":"100","author":"PM Clement","year":"2012","unstructured":"Clement, P. M., Hanauske-Abel, H. M., Wolff, E. C., Kleinman, H. K.\n& Park, M. H. The antifungal drug ciclopirox inhibits deoxyhypusine and\nproline hydroxylation, endothelial cell growth and angiogenesis in vitro.\nInt. J. Cancer\n100, 491\u2013498 (2012).","journal-title":"Int. J. Cancer"},{"key":"2779_CR8","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","volume":"114","author":"Y Eberhard","year":"2009","unstructured":"Eberhard, Y. et al. Chelation of intracellular iron with the\nantifungal agent ciclopirox olamine induces cell death in leukemia and myeloma\ncells. Blood\n114, 3064\u20133073\n(2009).","journal-title":"Blood"},{"key":"2779_CR9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/ijc.25255","volume":"127","author":"H Zhou","year":"2010","unstructured":"Zhou, H. et al. The antitumor activity of the fungicide ciclopirox.\nInt. J. Cancer\n127, 2467\u20132477\n(2010).","journal-title":"Int. J. Cancer"},{"key":"2779_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bcp.2016.07.005","volume":"116","author":"H Zhou","year":"2016","unstructured":"Zhou, H. et al. Ciclopirox olamine inhibits mTORC1 signaling by\nactivation of AMPK. Biochem. Pharmacol.\n116, 39\u201350 (2016).","journal-title":"Biochem. Pharmacol."},{"key":"2779_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161509","volume":"11","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. Antileukemia effect of ciclopirox olamine is mediated\nby downregulation of intracellular ferritin and inhibition beta-catenin-c-Myc\nsignaling pathway in glucocorticoid resistant T-ALL cell lines. PLoS ONE\n11, e0161509 (2016).","journal-title":"PLoS ONE"},{"key":"2779_CR12","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1158\/0008-5472.CAN-16-0826","volume":"77","author":"J Yang","year":"2017","unstructured":"Yang, J. et al. Targeting histone demethylases in MYC-driven\nneuroblastomas with ciclopirox. Cancer Res.\n77, 4626\u20134638 (2017).","journal-title":"Cancer Res."},{"key":"2779_CR13","doi-asserted-by":"publisher","first-page":"10140","DOI":"10.18632\/oncotarget.2471","volume":"5","author":"H Zhou","year":"2014","unstructured":"Zhou, H. et al. Ciclopirox induces autophagy through reactive\noxygen species-mediated activation of JNK signaling pathway. Oncotarget\n5, 10140\u201310150\n(2014).","journal-title":"Oncotarget"},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.7150\/thno.34663","volume":"9","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. CPX targeting DJ-1 triggers ROS-induced cell death\nand protective autophagy in colorectal cancer. Theranostics\n9, 5577\u20135594 (2019).","journal-title":"Theranostics"},{"key":"2779_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/biom9110688","volume":"9","author":"YM Huang","year":"2019","unstructured":"Huang, Y. M. et al. Gene expression signature-based approach\nidentifies antifungal drug ciclopirox as a novel inhibitor of HMGA2 in\ncolorectal cancer. Biomolecules\n9, 688 (2019).","journal-title":"Biomolecules"},{"key":"2779_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajh.23640","volume":"89","author":"MD Minden","year":"2014","unstructured":"Minden, M. D. et al. Oral ciclopirox olamine displays biological\nactivity in a phase I study in patients with advanced hematologic malignancies.\nAm. J. Hematol.\n89, 363\u2013368 (2014).","journal-title":"Am. J. Hematol."},{"key":"2779_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tcb.2003.11.001","volume":"14","author":"DT Rutkowski","year":"2004","unstructured":"Rutkowski, D. T. & Kaufman, R. J. A trip to the ER: coping\nwith stress. Trends Cell Biol.\n14, 20\u201328 (2004).","journal-title":"Trends Cell Biol."},{"key":"2779_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nature13228","volume":"510","author":"P van Galen","year":"2014","unstructured":"van Galen, P. et al. The unfolded protein response governs\nintegrity of the haematopoietic stem-cell pool during stress. Nature\n510, 268\u2013272 (2014).","journal-title":"Nature"},{"key":"2779_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz, C. & Papa, F. R. The unfolded protein response and\ncell fate control. Mol. Cell\n69, 169\u2013181 (2018).","journal-title":"Mol. Cell"},{"key":"2779_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","volume":"25","author":"HJ Clarke","year":"2014","unstructured":"Clarke, H. J., Chambers, J. E., Liniker, E. & Marciniak, S.\nJ. Endoplasmic reticulum stress in malignancy. Cancer\nCell\n25, 563\u2013573 (2014).","journal-title":"Cancer Cell"},{"key":"2779_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz, C. The unfolded protein response: controlling cell fate\ndecisions under ER stress and beyond. Nat. Rev. Mol.\nCell Biol.\n13, 89\u2013102 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2779_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce, M. et al. A selective inhibitor of eIF2alpha\ndephosphorylation protects cells from ER stress. Science\n307, 935\u2013939 (2005).","journal-title":"Science"},{"key":"2779_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S1097-2765(00)80330-5","volume":"5","author":"HP Harding","year":"2000","unstructured":"Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H. & Ron,\nD. Perk is essential for translational regulation and cell survival during the\nunfolded protein response. Mol. Cell\n5, 897\u2013904 (2000).","journal-title":"Mol. Cell"},{"key":"2779_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/iub.1272","volume":"66","author":"L Halperin","year":"2014","unstructured":"Halperin, L., Jung, J. & Michalak, M. The many functions of\nthe endoplasmic reticulum chaperones and folding enzymes. IUBMB Life\n66, 318\u2013326 (2014).","journal-title":"IUBMB Life"},{"key":"2779_CR25","first-page":"80","volume":"3","author":"ER Perri","year":"2015","unstructured":"Perri, E. R., Thomas, C. J., Parakh, S., Spencer, D. M. &\nAtkin, J. D. The unfolded protein response and the role of protein disulfide\nisomerase in neurodegeneration. Front. Cell Dev.\nBiol.\n3, 80 (2015).","journal-title":"Front. Cell Dev. Biol."},{"key":"2779_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/BJ20141423","volume":"469","author":"OB Oka","year":"2015","unstructured":"Oka, O. B., Yeoh, H. Y. & Bulleid, N. J. Thiol-disulfide\nexchange between the PDI family of oxidoreductases negates the requirement for\nan oxidase or reductase for each enzyme. Biochem.\nJ.\n469, 279\u2013288 (2015).","journal-title":"Biochem. J."},{"key":"2779_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2018.06.012","volume":"432","author":"L Lan","year":"2018","unstructured":"Lan, L. et al. Deferoxamine suppresses esophageal squamous cell\ncarcinoma cell growth via ERK1\/2 mediated mitochondrial dysfunction. Cancer Lett.\n432, 132\u2013143 (2018).","journal-title":"Cancer Lett."},{"key":"2779_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-cellbio-111315-125024","volume":"32","author":"A Gallo","year":"2016","unstructured":"Gallo, A., Vannier, C. & Galli, T. Endoplasmic\nreticulum-plasma membrane associations: structures and functions. Annu. Rev. Cell Dev. Biol.\n32, 279\u2013301 (2016).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2779_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/carcin\/bgh283","volume":"26","author":"R Gerl","year":"2005","unstructured":"Gerl, R. & Vaux, D. L. Apoptosis in the development and\ntreatment of cancer. Carcinogenesis\n26, 263\u2013270 (2005).","journal-title":"Carcinogenesis"},{"key":"2779_CR30","doi-asserted-by":"publisher","first-page":"5729710","DOI":"10.1155\/2019\/5729710","volume":"2019","author":"A Walczak","year":"2019","unstructured":"Walczak, A., Gradzik, K., Kabzinski, J., Przybylowska-Sygut, K.\n& Majsterek, I. The role of the ER-induced UPR pathway and the efficacy\nof its inhibitors and inducers in the inhibition of tumor progression. Oxid. Med. Cell. Longev.\n2019, 5729710 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2779_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ceb.2004.09.012","volume":"16","author":"RV Rao","year":"2004","unstructured":"Rao, R. V. & Bredesen, D. E. Misfolded proteins,\nendoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol.\n16, 653\u2013662 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2779_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/sj.cdd.4401378","volume":"11","author":"RV Rao","year":"2004","unstructured":"Rao, R. V., Ellerby, H. M. & Bredesen, D. E. Coupling\nendoplasmic reticulum stress to the cell death program. Cell Death Differ.\n11, 372\u2013380 (2004).","journal-title":"Cell Death Differ."},{"key":"2779_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00018-018-2967-9","volume":"76","author":"I Buondonno","year":"2019","unstructured":"Buondonno, I. et al. Endoplasmic reticulum-targeting doxorubicin: a\nnew tool effective against doxorubicin-resistant osteosarcoma. Cell Mol. Life Sci.\n76, 609\u2013625 (2019).","journal-title":"Cell Mol. Life Sci."},{"key":"2779_CR34","doi-asserted-by":"publisher","first-page":"110005","DOI":"10.1016\/j.biopha.2020.110005","volume":"125","author":"H Liu","year":"2020","unstructured":"Liu, H. et al. Aspirin exerts anti-tumor effect through inhibiting\nBlimp1 and activating ATF4\/CHOP pathway in multiple myeloma. Biomed. Pharmacother.\n125, 110005 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"2779_CR35","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1089\/ars.2007.1782","volume":"9","author":"JD Malhotra","year":"2007","unstructured":"Malhotra, J. D. & Kaufman, R. J. Endoplasmic reticulum\nstress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal.\n9, 2277\u20132293 (2007).","journal-title":"Antioxid. Redox Signal."},{"key":"2779_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2019.01.034","volume":"449","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Wang, K., Jin, Y. & Sheng, X. Endoplasmic\nreticulum proteostasis control and gastric cancer. Cancer Lett.\n449, 263\u2013271 (2019).","journal-title":"Cancer Lett."},{"key":"2779_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2011.03.001","volume":"36","author":"U Woehlbier","year":"2011","unstructured":"Woehlbier, U. & Hetz, C. Modulating stress responses by the\nUPRosome: a matter of life and death. Trends Biochem.\nSci.\n36, 329\u2013337 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"2779_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biocel.2007.01.020","volume":"40","author":"K Ameri","year":"2008","unstructured":"Ameri, K. & Harris, A. L. Activating transcription factor\n4. Int. J. Biochem. Cell Biol.\n40, 14\u201321 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2779_CR39","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/onc.2010.590","volume":"30","author":"Y Luo","year":"2011","unstructured":"Luo, Y. et al. The fungicide ciclopirox inhibits lymphatic\nendothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling\npathway. Oncogene\n30, 2098\u20132107 (2011).","journal-title":"Oncogene"},{"key":"2779_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next\ngeneration. Cell\n144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2779_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature13110","volume":"508","author":"K Birsoy","year":"2014","unstructured":"Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity\nto glucose limitation and biguanides. Nature\n508, 108\u2013112 (2014).","journal-title":"Nature"},{"key":"2779_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti, M. V. & Locasale, J. W. The Warburg effect: how\ndoes it benefit cancer cells? Trends Biochem.\nSci.\n41, 211\u2013218 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"2779_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace, D. C. Mitochondria and cancer. Nat. Rev. Cancer\n12, 685\u2013698 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2779_CR44","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1038\/ncomms4295","volume":"5","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Induction of mitochondrial dysfunction as a\nstrategy for targeting tumour cells in metabolically compromised\nmicroenvironments. Nat. Commun.\n5, 3295 (2014).","journal-title":"Nat. Commun."},{"key":"2779_CR45","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","volume":"1807","author":"C Jose","year":"2011","unstructured":"Jose, C., Bellance, N. & Rossignol, R. Choosing between\nglycolysis and oxidative phosphorylation: a tumor\u2019s dilemma?. Biochim. Biophys. Acta\n1807, 552\u2013561 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2779_CR46","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/S0021-9258(17)30124-2","volume":"254","author":"LJ Reitzer","year":"1979","unstructured":"Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that\nglutamine, not sugar, is the major energy source for cultured HeLa cells.\nJ. Biol. Chem.\n254, 2669\u20132676\n(1979).","journal-title":"J. Biol. Chem."},{"key":"2779_CR47","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.biocel.2010.07.010","volume":"42","author":"S Rodriguez-Enriquez","year":"2010","unstructured":"Rodriguez-Enriquez, S. et al. Oxidative phosphorylation is impaired\nby prolonged hypoxia in breast and possibly in cervix carcinoma. Int. J. Biochem. Cell Biol.\n42, 1744\u20131751 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2779_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","volume":"118","author":"M Jur\u00edkov\u00e1","year":"2016","unstructured":"Jur\u00edkov\u00e1, M., Danihel, \u013d., Pol\u00e1k,\n\u0160. & Varga, I. Ki67, PCNA, and MCM proteins: markers of\nproliferation in the diagnosis of breast cancer. Acta\nHistochem.\n118, 544\u2013552 (2016).","journal-title":"Acta Histochem."},{"key":"2779_CR49","doi-asserted-by":"publisher","first-page":"9423907","DOI":"10.1155\/2019\/9423907","volume":"2019","author":"C Scheau","year":"2019","unstructured":"Scheau, C. et al. The role of matrix metalloproteinases in the\nepithelial-mesenchymal transition of hepatocellular carcinoma. Anal. Cell. Pathol.\n2019, 9423907\u20139423907\n(2019).","journal-title":"Anal. Cell. Pathol."},{"key":"2779_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10911-010-9177-x","volume":"15","author":"ES Radisky","year":"2010","unstructured":"Radisky, E. S. & Radisky, D. C. Matrix\nmetalloproteinase-induced epithelial-mesenchymal transition in breast cancer.\nJ. Mammary Gland Biol. Neoplasia\n15, 201\u2013212 (2010).","journal-title":"J. Mammary Gland Biol. Neoplasia"}],"updated-by":[{"DOI":"10.1038\/s41419-020-02868-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02779-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:03:07Z","timestamp":1773676987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02779-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02779-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-020-02868-1","URL":"https:\/\/doi.org\/10.1038\/s41419-020-02868-1","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"582"}}